A Pocket-Sized Window into Metabolism
Researchers at ETH Zurich have unveiled a portable breath-analysis device that tracks metabolic shifts in real time. By detecting acetone concentrations in exhaled air, the sensor offers a non-invasive alternative to traditional laboratory mass spectrometry. The findings, published in the journal Device, confirm the technology can monitor fat metabolism following exercise, fasting, or specific dietary intake.
Tracking the Chemistry of Fat Burning
The device targets acetone, a volatile organic compound created when the body turns to fat oxidation for fuel. When carbohydrates are scarce, the liver breaks down fatty acids into ketone bodies. One of these partially decomposes into acetone, which the lungs then expel.
The research team, led by Andreas Güntner, designed the sensor to detect acetone concentrations ranging from 0.2 to 45 parts per million. To ensure precision, a smartphone application guides users through the breathing process, capturing air from deep within the lungs. The system filters out contaminants and automatically rejects samples that fall below quality thresholds, delivering results in approximately 90 seconds.
In a study of 12 healthy adults aged 20 to 37, the team compared 312 breath samples against a high-precision laboratory mass spectrometer. The data revealed a high correlation between the portable device and the reference method, showing distinct metabolic markers across three primary conditions:
- Post-Exercise: Acetone levels rose significantly during the recovery phase following intense training, indicating a shift toward fat utilization.
- Dietary Impact: Following a carbohydrate-rich meal, acetone levels decreased, while they remained elevated after fat-rich meals.
- Fasting: Acetone concentrations showed a steady increase during periods of fasting.
From Technical Proof to Clinical Reality
While these initial results are promising, the study is limited by a small, homogenous sample size of healthy, normal-weight individuals. The researchers noted that the device does not provide a direct readout of total body fat mass or weight loss. Because metabolic rates vary due to fitness levels and carbohydrate storage, the current data serves as a technical validation rather than a clinical weight-loss tool.
The device is currently being commercialized under the name “Nutrion” by Alivion, an ETH Zurich spin-off. Two of the study’s authors hold financial stakes in the company. Further independent, large-scale clinical trials are required to determine the device’s efficacy for older populations or patients with specific metabolic disorders.
Technical Specifications
- Technology: Portable sensor for real-time metabolic monitoring.
- Target Biomarker: Acetone in exhaled breath.
- Measurement Time: Approximately 90 seconds.
- Validation: 312 samples compared against mass spectrometry.
- Current Status: Technical validation complete; clinical utility requires further study.
Related reading